Medication and DNA
The best treatment
lies within your DNA!
Your genes can indicate
the appropriate medication
A patient’s genetic makeup may influence the effectiveness of medication up to 95%. There have been reported cases of people experiencing serious side effects after taking one drug, while they present no side effects with other drugs. Our genetic profile accounts for inter-individual differences in response to the same drug type and dose by patients with the same disease. We are all different and therefore react in different ways to a specific treatment.
Οφέλη Medical DNA Τests
What does the evidence show
It is now known that patients with the same disease respond differently to the same treatment. A patient’s genetic profile plays a key role in treatment response and can influence the effectiveness of patients’ medication up to 95%.
34% of CNS drugs’ side effects are caused by the patient’s genetic profile and not by drug interactions with other drugs.
In the near future, Pharmacogenomics is expected to be a routine procedure in all patients before prescribing antidepressants. This is also the goal for medical practice in psychiatry.
A study in 501 Greek patients, genotyped for three P450 enzymes, showed that a high proportion of patients are expected to exhibit poor or intermediate metabolism of drugs metabolised by one of the P450 enzymes (39% for CYP2C9, 27% for CYP2C19 and 38% for CYP2D6). This is consistent with other Caucasian populations. Similarly, more than 70% of the patients are expected to exhibit intermediate or enhanced gene-drug interactions to a range of CNS drugs.
* Listed above are some of the most representative researches in the Science of Pharmacogenomics